Australia's Drug Gardasil Said To Cause Numerous Side Effects
This article was originally published in PharmAsia News
Executive SummaryAustralian developed Gardasil to protect women against the human papillomavirus has been shown in a study to cause side effects among thousands of women in the United States. The drug, developed by Australia's CSL, has been given to millions of young Australian women as part of a national campaign against HPV. The three-shot regiment has led to blood clots, dizziness, fainting and nausea in more than 12,000 U.S. women, according the published study. Australian doctors caution, however, that the number of reactions is still relatively low when one considers millions of women receive the vaccine. (Click here for more
You may also be interested in...
The amyloid-targeting drug is years behind Biogen/Eisai’s aducanumab, but its subcutaneous administration and the GRADUATE studies’ design could give Roche’s gantenerumab an advantage.
Correvio's atrial fibrillation drug Brinavess will return to a US FDA advisory committee more than a decade after the agency first declined to approve the drug; FDA still has a series of cardiovascular safety concerns related to the drug and is not convinced by data from the European experience.
FerGene bladder cancer therapy achieved a complete response in more than half of patients in its pivotal trial. The joint venture now looks to commercialization and potential expansion of indications.